Updated Jul 16, 2026
Ezekowitz Alan has filed 4 SEC Form 4 filings across 3 companies in the last 90 days — selling. Lifetime open-market sales: $66K.
Alan Ezekowitz is listed as a director of Organon & Co. in the SEC filing context provided (most recent filing dated 2026-06-15). Based on the filing, he is a corporate insider serving on Organon’s board. Specific prior roles, education, and achievements are not detailed in the given context.
| Role | Insider |
|---|---|
| Notability | 60/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-30 | FULC | Fulcrum Therapeutics, Inc. | S — Open-market sale | 18.0K | $3.65 | $66K |
Alan Ezekowitz is listed as a director of Organon & Co. in the SEC filing context provided (most recent filing dated 2026-06-15). Based on the filing, he is a corporate insider serving on Organon’s board. Specific prior roles, education, and achievements are not detailed in the given context.…
4 primary Form 4 filings in the last 90 days, covering 3 companies.
Recorded transactions: 0 open-market purchases () and 1 open-market sales ($66K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Ezekowitz Alan profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.